PATH was commissioned by Crucell to improve understanding of the impact on health care waste management of a new presentation of liquid pentavalent vaccine targeted for use in developing countries. This report details the findings of a quantitative and qualitative analysis PATH conducted on the differences between delivery of Quinvaxem® in the Uniject™ injection system and delivery in a vial using a syringe.
Corporate author(s): PATH
Publication date: September 2014
797 KB PDF
Hard copies are not available.
Some digital files may be saved at low resolutions to conserve file size. Versions with higher quality may be available; see the contact information below to enquire.
Related regions: Africa
For more information…
Contact: PATH Publications
Mailing address: PATH, PO Box 900922, Seattle, WA 98109 USA